+86 189 1304 2753 product@eynoslifescience.com

Reports about Eynos in national and local media, plus one company profile. Media pieces are summarised in English; the full Chinese original is linked from each page.

Company news 10 November 2026

China Industry News reports Eynos: a full-stack cell-isolation reagent line

China Industry News (cinn.cn) covered Eynos at the Cell Biology Industry Conference and its biopharma expo: six isolation series, direct antibody conjugation versus the biotin-streptavidin indirect route, and three QC practices — standardised manuals, batch COAs searchable by catalogue number, and catalogue-to-literature cross-linking. The dose-titration test on the human CD4 beads is described as well.

Company news 22 April 2026

Xinhua News Agency interviews founder Wang Yafeng on university spin-offs

Xinhua's "Xinhua Viewpoint" featured the National Center for Technology Transfer in Biomedicine (Jiangsu, Nanjing) in the Jiangbei New Area, where Eyn

Company news 15 September 2026

Nanjing Pilot Free Trade Zone reports Eynos as a translation case

The zone's "Free Trade Circle" column covered the National Center for Technology Transfer in Biomedicine, with Eynos appearing as one of the case stud

Company news 14 August 2025

Nanjing Free Trade Zone reports Eynos platforms and 18 cell-isolation kits

The Nanjing Pilot Free Trade Zone published a report on the biomedicine ecosystem in the Jiangbei New Area, describing Eynos' three technology platfor

Company news 25 June 2025

Xiningshang interview: a vertical approach to localising immune cell-isolation reagents

Xiningshang published an interview with Eynos roughly half a year after the company was founded, covering its first series of immune cell-isolation ki

Company news 12 May 2025

Nanjing Daily: 30+ projects landed in six months at the national transfer centre

Nanjing Daily reported on the National Center for Technology Transfer in Biomedicine using Eynos as a case study of how a doctoral project becomes a r

Company news 12 May 2025

Nanjing University reports on the "first mile" of research translation

Nanjing University's own site covered the Nanjing Biomedicine Branch Centre and the founding of Eynos by Wang Yafeng, a biology PhD and postdoctoral r

Company news 6 April 2025

Eynos at the national translation platform, reported by Nanjing Broadcasting

Episode 117 of the theory programme "Study Ningjuli", produced by Nanjing Broadcasting under the guidance of the municipal publicity department, visit

Company news 20 January 2025

Xinhua Daily: industrialisation from a 100-square-metre laboratory

Xinhua Daily's Jiangbei New Area feature covered Eynos in its chapter on national-level platforms, noting that the team was assembled within one to tw

Company news Company profile

What kind of company is Eynos LifeScience?

Eynos (Nanjing) LifeScience Co., Ltd. is a life-science reagent company focused on immune cells. The core catalogue is magnetic cell-isolation kits; c

Want the full story behind any of these reports?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.